Yunting Luo

1.0k total citations
27 papers, 814 citations indexed

About

Yunting Luo is a scholar working on Molecular Biology, Oncology and General Health Professions. According to data from OpenAlex, Yunting Luo has authored 27 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 4 papers in General Health Professions. Recurrent topics in Yunting Luo's work include Ubiquitin and proteasome pathways (5 papers), Cancer Mechanisms and Therapy (3 papers) and Microtubule and mitosis dynamics (3 papers). Yunting Luo is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Cancer Mechanisms and Therapy (3 papers) and Microtubule and mitosis dynamics (3 papers). Yunting Luo collaborates with scholars based in United States, China and Australia. Yunting Luo's co-authors include Harshani R. Lawrence, Nicholas J. Lawrence, Saı̈d M. Sebti, Uwe Rix, Wayne C. Guida, Lily L. Remsing Rix, Gabriëla Wright, Roberta Pireddu, E. Schönbrunn and John M. Koomen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Yunting Luo

25 papers receiving 808 citations

Peers

Countries citing papers authored by Yunting Luo

Since Specialization

Citations

This map shows the geographic impact of Yunting Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunting Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunting Luo more than expected).

Fields of papers citing papers by Yunting Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunting Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunting Luo. The network helps show where Yunting Luo may publish in the future.

Co-authorship network of co-authors of Yunting Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yunting Luo. A scholar is included among the top collaborators of Yunting Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunting Luo. Yunting Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effects of sarcopenia on the prognosis of patients with acute-on-chronic liver failure: a systematic review and meta-analysis 2025 ·Frontiers in Nutrition ·Wenyan Li, Rong Deng, Yunting Luo, Hong Li, Fang Chen, (unknown), Min Liu, Qian Liu, (unknown), Lixia Zhang	0
2	The Perception of Career Planning and Development Among Senior Clinical Nurses: A Qualitative Analysis 2025 ·International Nursing Review ·Yunting Luo, Yanling Chen, Mei Feng	0
3	Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting 2022 ·Science Translational Medicine ·(unknown), Kiran Mahajan, Arun Renganathan, Cody Weimholt, Jingqin Luo, Vandna Kukshal, Joseph M. Jez, (unknown), Bo Zhang, Tiandao Li, Bin Fang, Yunting Luo, Nicholas J. Lawrence, Harshani R. Lawrence, Felix Y. Feng, Nupam P. Mahajan	19
4	Barriers and facilitators of diabetes management by continuous glucose monitoring systems among adults with type 2 diabetes: a protocol of qualitative systematic review 2021 ·BMJ Open ·(unknown), (unknown), Adeel Khoja, Yunting Luo, (unknown), Qian He, Xuan Zhao, Juan Wang, (unknown), (unknown)	7
5	Willingness to participate in front‐line work during the COVID‐19 pandemic: A cross‐sectional study of nurses from a province in South‐West China 2021 ·Journal of Nursing Management ·Yunting Luo, Xianqiong Feng, (unknown), Dan Zhang, Hong Xiao, Ning Li	18
6	The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors 2021 ·Cell chemical biology ·Vinayak Palve, Claire E. Knezevic, Daniel S. Bejan, Yunting Luo, Xueli Li, (unknown), Eric A. Welsh, Bin Fang, Fumi Kinose, Eric B. Haura, Álvaro N.A. Monteiro, John M. Koomen, Michael S. Cohen, Harshani R. Lawrence, Uwe Rix	25
7	Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol 2020 ·Systematic Reviews ·(unknown), Yunting Luo, (unknown), Adeel Khoja, Qian He, (unknown), Xuan Zhao, (unknown)	14
8	Study on effects of pestle needle on foot current sensory threshold and clinical symptoms in patients at high?risk of diabetic foot 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Yunting Luo, (unknown), Yu Wang, (unknown), (unknown), (unknown), (unknown)	1
9	Abstract B021: PARP16 is a novel target of talazoparib which contributes to synergy with adavosertib in SCLC 2019 ·Molecular Cancer Therapeutics ·Vinayak Palve, (unknown), Yunting Luo, Xueli Li, (unknown), Eric A. Welsh, Bin Fang, Fumi Kinose, Eric B. Haura, Álvaro N.A. Monteiro, John M. Koomen, Harshani R. Lawrence, Uwe Rix	1
10	Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition 2017 ·Molecular Oncology ·Manali Phadke, Lily L. Remsing Rix, Inna Smalley, (unknown), Yunting Luo, Harshani R. Lawrence, Braydon Schaible, Y. Ann Chen, Uwe Rix, Keiran S.M. Smalley	33
11	Dual Targeting of WEE1 and PLK1 by AZD1775 Elicits Single Agent Cellular Anticancer Activity 2017 ·ACS Chemical Biology ·Gabriëla Wright, Volha A. Golubeva, Lily L. Remsing Rix, Norbert Berndt, Yunting Luo, Grace Ward, Jhanelle E. Gray, E. Schönbrunn, Harshani R. Lawrence, Álvaro N.A. Monteiro, Uwe Rix	57
12	Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets 2016 ·Cell chemical biology ·Claire E. Knezevic, Gabriëla Wright, Lily L. Remsing Rix, Woosuk Kim, Brent M. Kuenzi, Yunting Luo, (unknown), John M. Koomen, Eric B. Haura, Álvaro N.A. Monteiro, Caius G. Radu, Harshani R. Lawrence, Uwe Rix	77
13	Development of Novel ACK1/TNK2 Inhibitors Using a Fragment-Based Approach 2015 ·Journal of Medicinal Chemistry ·Harshani R. Lawrence, Kiran Mahajan, Yunting Luo, Daniel Zhang, (unknown), Miles K. Huseyin, (unknown), (unknown), Sevil Özcan, Nupam P. Mahajan, Nicholas J. Lawrence	37
14	[Copracrasia treated with acupuncture and moxibustion: a randomized controlled trial]. 2015 ·PubMed ·Yu Zhao, Yunting Luo, (unknown), Jing Wu, Mengyue Liu, Ning Li	3
15	Dual Aurora A and JAK2 kinase blockade effectively suppresses malignant transformation 2014 ·Oncotarget ·Hua Yang, Harshani R. Lawrence, Aslamuzzaman Kazi, (unknown), (unknown), Yunting Luo, Uwe Rix, E. Schönbrunn, Nicholas J. Lawrence, Saı̈d M. Sebti	19
16	GSK3 Alpha and Beta Are New Functionally Relevant Targets of Tivantinib in Lung Cancer Cells 2013 ·ACS Chemical Biology ·Lily L. Remsing Rix, Brent M. Kuenzi, Yunting Luo, Elizabeth Remily-Wood, Fumi Kinose, Gabriëla Wright, Jiannong Li, John M. Koomen, Eric B. Haura, Harshani R. Lawrence, Uwe Rix	74
17	Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112 2010 ·Biochemical Pharmacology ·Liwei Chen, (unknown), Latanya M. Scott, Harshani R. Lawrence, Yuan Ren, Yunting Luo, Xin Wu, Shen‐Shu Sung, Wayne C. Guida, Saı̈d M. Sebti, Nicholas J. Lawrence, Jie Wu	31
18	Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors 2010 ·Bioorganic & Medicinal Chemistry ·Harshani R. Lawrence, Aslamuzzaman Kazi, Yunting Luo, Robert D. Kendig, (unknown), (unknown), Kenyon G. Daniel, Daniel N. Santiago, Wayne C. Guida, Saı̈d M. Sebti	64
19	Effect of Ack1 tyrosine kinase inhibitor on ligand‐independent androgen receptor activity 2010 ·The Prostate ·Kiran Mahajan, Sridevi Challa, Domenico Coppola, Harshani R. Lawrence, Yunting Luo, (unknown), Weiwei Zhu, Y. Ann Chen, Nicholas J. Lawrence, Nupam P. Mahajan	77
20	Inhibitors of Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (Shp2) Based on Oxindole Scaffolds 2008 ·Journal of Medicinal Chemistry ·Harshani R. Lawrence, Roberta Pireddu, Liwei Chen, Yunting Luo, Shen‐Shu Sung, Ann Marie Szymanski, M.L. Richard Yip, Wayne C. Guida, Saı̈d M. Sebti, Jie Wu, Nicholas J. Lawrence	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact